Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
WuXi Vaccines Launches Its First Vaccines CDMO Site in China
Contributed by:
PR Newswire
Tags
WuXi-CDMO
More Like This
WuXi Biologics to Increase Manufacturing Capacity in Massachusetts
WuXi Biologics Germany to Enhance Capabilities with New Prefilled Syringes Line
WuXi Biologics' Four Manufacturing Facilities and Biosafety Testing Center Certified Again by European Medicines Agency for Ten Biologics
WuXi Biologics Successfully Completes First Scale-Up of High-Productivity Bioprocessing Platform WuXiUI™ in 2,000L GMP Manufacturing
WuXi Biologics Successfully Completes First 16,000L Manufacturing Run in Ireland
WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates
Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine
WuXi Biologics Reports Solid 2024 Interim Results
